AK Medical Holdings Limited (HKG:1789)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.285
-0.145 (-3.27%)
Oct 22, 2026, 4:08 PM HKT

AK Medical Holdings Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5531,4821,3461,0941,052761.44
Revenue Growth
4.76%10.11%23.09%3.98%38.16%-26.46%
Gross Profit
974.5897.4808.19674.49636.44499.19
Operating Income
426.86373.88300.78211.48238.3499.44
Net Income
375.2339.09273.93182.1204.7792.62
Earnings Per Share
0.340.300.240.160.180.08
EPS Growth
10.90%24.18%52.50%-11.11%125.00%-71.43%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Elimination of Inter-Segment
-44.67-43.14-43.59-52.21-42.38-51.58
Orthopedic Implants - China
1,4201,3551,226993.59977.67687.41
Orthopedic Implants - United Kingdom
177.36170.6164.2152.49116.76125.62
Total
1,5531,4821,3461,0941,052761.44

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3371,2451,027729.551,045844.23
Total Debt
12.9386.4399.3984.238.7841.56
Net Cash (Debt)
1,3241,159927.29645.351,007802.67
Net Cash Growth
14.23%24.99%43.69%-35.89%25.42%-8.52%
Net Cash Per Share
1.191.040.830.580.900.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-395.98451.0733.94242.92176.62
Capital Expenditures
--105.67-152.82-183.8-115.2-58.76
Free Cash Flow
-290.31298.25-149.86127.72117.86
Free Cash Flow Growth
--2.66%--8.36%-1.79%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.75%60.54%60.03%61.66%60.49%65.56%
Operating Margin
27.49%25.22%22.34%19.33%22.66%13.06%
Pretax Margin
28.21%26.64%23.75%21.13%22.84%14.26%
Profit Margin
24.16%22.87%20.34%16.65%19.46%12.16%
FCF Margin
-19.58%22.15%-13.70%12.14%15.48%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1180.1060.0680.0410.0530.020
Dividend Per Share Growth
63.89%56.73%65.64%-23.04%160.59%-39.53%
Dividend Yield
2.75%2.07%1.49%0.72%0.61%0.38%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.0516.9818.6835.0147.1964.77
Forward PE
9.5715.2215.7720.9837.2332.47
P/FCF Ratio
-19.8317.16-75.6550.90
PS Ratio
2.703.883.805.839.187.88